FDA Approves Nourianz (istradefylline) as an Add-On Drug to Treat Off Episodes in Adults with Parkinson ’s Disease

August 27, 2019 -- The U.S. Food and Drug Administration today approved Nourianz (istradefylline) tablets as an add-on treatment to levodopa/carbidopa in adult patients with Parkinson’s disease (PD) experiencing " off " episodes. An " off " ...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news